| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers U > Headlines for U.S. Renal Care Inc. > News item |
S&P rates U.S. Renal Care loan B-
S&P said it assigned its B- issue-level rating and 3 recovery rating to U.S. Renal Care Inc.'s proposed $150 million term loan. The 3 recovery rating indicates an expectation for meaningful (50%-70%; rounded estimate: 55%) recovery in default.
The rating is the same as U.S. Renal Care’s issuer rating.
The company intends to use the proceeds for general corporate purposes and to pay related fees and expenses.
The outlook is stable.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.